{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:19:14Z","timestamp":1791908354035,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.intimp.2024.112403","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T22:50:33Z","timestamp":1719355833000},"page":"112403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Peripheral Th17\/Treg imbalance in Chinese patients with untreated antisynthetase syndrome associated interstitial lung disease"],"prefix":"10.1016","volume":"138","author":[{"given":"Yanhua","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bomiao","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfei","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuyuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7464-3250","authenticated-orcid":false,"given":"Lan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.112403_b0005","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/BOR.0000000000000104","article-title":"Interstitial lung disease associated with the idiopathic inflammatory myopathies and the antisynthetase syndrome: recent advances","volume":"26","author":"Hallowell","year":"2014","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.intimp.2024.112403_b0010","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/rheumatology\/kep078","article-title":"Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression","volume":"48","author":"Gunawardena","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.intimp.2024.112403_b0015","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.resinv.2016.01.005","article-title":"Severe respiratory failure as a presenting feature of an interstitial lung disease associated with anti-synthetase syndrome (ASS)","volume":"54","author":"Piroddi","year":"2016","journal-title":"Respir. Investig."},{"key":"10.1016\/j.intimp.2024.112403_b0020","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3899\/jrheum.161480","article-title":"Clinical Profiles and Prognosis of Patients with Distinct Antisynthetase Autoantibodies","volume":"44","author":"Shi","year":"2017","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.intimp.2024.112403_b0025","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2174\/1381612827666211115165353","article-title":"Update on Myositis Therapy: From Today's Standards to Tomorrow's Possibilities","volume":"28","author":"Glaubitz","year":"2022","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.intimp.2024.112403_b0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/JIR.S10602","article-title":"Immunology of fibrotic lung disease: managing infections whilst preventing autoimmunity?","volume":"4","author":"H\u00fcgle","year":"2011","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.intimp.2024.112403_b0035","doi-asserted-by":"crossref","first-page":"247","DOI":"10.14336\/AD.2020.0410","article-title":"The Role of Immune Cells in the Pathogenesis of Idiopathic Inflammatory Myopathies","volume":"12","author":"Zhao","year":"2021","journal-title":"Aging. Dis."},{"key":"10.1016\/j.intimp.2024.112403_b0040","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00281-019-00733-8","article-title":"The Pathogenicity of Th17 Cells in Autoimmune Diseases","volume":"41","author":"Yasuda","year":"2019","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.intimp.2024.112403_b0045","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.3390\/jcm9051356","article-title":"Anti-Aminoacyl Transfer-RNA-Synthetases(Anti-tRNA) Autoantibodies Associated with Interstitial Lung Disease: Pulmonary Disease Progression has a Persistent Elevation of the Th17 Cytokine Profile","volume":"9","author":"Ramos-Martinez","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2024.112403_b0050","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jaut.2010.07.006","article-title":"Characterization of regulatory T cells in patients with dermatomyositis","volume":"35","author":"Antiga","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.intimp.2024.112403_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105912","article-title":"Absolute reduction of regulatory T cells and regulatory effect of short-term and low-dose IL-2 in polymyositis or dermatomyositis","volume":"77","author":"Feng","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.112403_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.579043","article-title":"Role of extracellular vesicles in autoimmune pathogenesis","volume":"11","author":"Wu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112403_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.55563\/clinexprheumatol\/qug8tf","article-title":"One year in review 2020: idiopathic inflammatory myopathies","volume":"39","author":"Zanframundo","year":"2021","journal-title":"Clin.Exp.Rheumatol."},{"key":"10.1016\/j.intimp.2024.112403_b0070","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1378\/chest.10-0180","article-title":"Interstitial Lung Disease Associated With the Idiopathic Inflammatory Myopathies : what progress has been made in the past 35 years?","volume":"138","author":"Connors","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.intimp.2024.112403_b0075","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1136\/ard.2003.017715","article-title":"Altered cytokine expression of peripheral blood lymphocytes in polymyositis and dermatomyositis","volume":"64","author":"Aleksza","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2024.112403_b0080","first-page":"82","article-title":"Peripheral blood lymphocyte subset counts in patients with dermatomyositis: clinical correlations and changes following therapy","volume":"82","author":"Viguier","year":"2003","journal-title":"Medicine(Baltimore)"},{"key":"10.1016\/j.intimp.2024.112403_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.845988","article-title":"Different Multivariable Risk Factors for Rapid Progressive Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis and Anti-Synthetase Syndrome","volume":"13","author":"Zuo","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112403_b0090","article-title":"Single-Cell Transcriptomics Reveals Peripheral Immune Responses in Anti-Synthetase Syndrome-Associated Interstitial Lung Disease","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112403_b0095","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.rmed.2017.10.020","article-title":"Clinical characteristics of patients with anti-aminoacyl-tRNA synthetase antibody positive idiopathic interstitial pneumonia","volume":"132","author":"Yura","year":"2017","journal-title":"Respir. Med."},{"key":"10.1016\/j.intimp.2024.112403_b0100","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2249.2002.01933.x","article-title":"Activation of pulmonary T cells in corticosteroid-resistant and-sensitive interstitial pneumonitis in dermatomyositis\/ polymyositis","volume":"129","author":"Kurasawa","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2024.112403_b0105","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/ar4116","article-title":"T cells in myositis","volume":"14","author":"Malmstrom","year":"2012","journal-title":"Arthritis.Res.Ther."},{"key":"10.1016\/j.intimp.2024.112403_b0110","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/rheumatology\/ket279","article-title":"Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy","volume":"53","author":"Venalis","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.intimp.2024.112403_b0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1081-1206(10)62426-X","article-title":"T-cell subsets (Th1 versus Th2)","volume":"85","author":"Romagnani","year":"2000","journal-title":"Ann.Allergy.Asthma.Immunol."},{"key":"10.1016\/j.intimp.2024.112403_b0120","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3389\/fimmu.2020.01142","article-title":"T cells in fibrosis and fibrotic diseases","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112403_b0125","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12325-022-02337-5","article-title":"Peripheral Treg Levels and Transforming Growth Factor-\u03b2 (TGF\u03b2) in Patients with Psoriatic Arthritis, A Systematic Review Meta-Analysis","volume":"40","author":"Su","year":"2023","journal-title":"Adv.Ther."},{"key":"10.1016\/j.intimp.2024.112403_b0130","doi-asserted-by":"crossref","first-page":"1058738","DOI":"10.1155\/2019\/1058738","article-title":"The Proportion of Regulatory T Cells in Patients with Ankylosing Spondylitis: A Meta-Analysis","volume":"2019","author":"Lai","year":"2019","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.intimp.2024.112403_b0135","doi-asserted-by":"crossref","first-page":"7103219","DOI":"10.1155\/2018\/7103219","article-title":"The Proportion of Regulatory T Cells in Patients with Systemic Lupus Erythematosus, A Meta-Analysis","volume":"2018","author":"Zhang","year":"2018","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.intimp.2024.112403_b0140","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1080\/03007995.2022.2065145","article-title":"Low-dose IL-2 therapy limits the reduction in absolute numbers of peripheral lymphocytes in systemic lupus erythematosus patients with infection","volume":"38","author":"Zhang","year":"2022","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.intimp.2024.112403_b0145","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2019-216246","article-title":"Circulating regulatory T cells were absolutely decreased in dermatomyositis\/polymyositis patients and restored by lowdose IL-2","volume":"80","author":"Zhang","year":"2021","journal-title":"Ann.Rheum.Dis."},{"key":"10.1016\/j.intimp.2024.112403_b0150","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X211011370","article-title":"Low-dose IL-2 therapy limits the reduction in absolute numbers of circulating regulatory T cells in rheumatoid arthritis","volume":"13","author":"Zhang","year":"2021","journal-title":"Ther.Adv. Musculoskelet. Dis."},{"key":"10.1016\/j.intimp.2024.112403_b0155","doi-asserted-by":"crossref","unstructured":"C. Scheinecker, L. G\u00f6schl, M. Bonelli, Treg cells in health and autoimmune diseases: New insights from single cell analysis, J.Autoimmun. 110 (2020)102376.","DOI":"10.1016\/j.jaut.2019.102376"},{"key":"10.1016\/j.intimp.2024.112403_b0160","first-page":"6106","article-title":"Imbalance of peripheral blood Th17\/Treg increases neutrophil-to-lymphocyte ratio in patients with dermatomyositis","volume":"15","author":"Zhang","year":"2023","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.intimp.2024.112403_b0165","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s10753-022-01747-5","article-title":"Decreased Th1 Cells and Increased Th2 Cells in Peripheral Blood Are Associated with Idiopathic Inflammatory Myopathies Patients with Interstitial Lung Disease","volume":"46","author":"Cheng","year":"2023","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2024.112403_b0170","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/cei.12445","article-title":"Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications","volume":"178","author":"Moran","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2024.112403_b0175","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/bjd.17079","article-title":"Measurement of cytokines, chemokines and association with clinical severity of DM\/CADM disease","volume":"179","author":"Chen","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.intimp.2024.112403_b0180","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1002\/art.30513","article-title":"Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients","volume":"63","author":"Marie","year":"2011","journal-title":"Arthritis.Rheum."},{"key":"10.1016\/j.intimp.2024.112403_b0185","article-title":"Interstitial lung disease in dermatomyositis without myositis-specific and myositis-associated autoantibodies: study of a series of 72 patients from a single cohort","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112403_b0190","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1007\/s10067-023-06570-3","article-title":"Prediction of progressive pulmonary fibrosis in patients with anti-synthetase syndrome-associated interstitial lung disease","volume":"42","author":"Fu","year":"2023","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.intimp.2024.112403_b0195","doi-asserted-by":"crossref","unstructured":"A.K.Anuja, P. Mehta, M.K. Singh, et al., Peripheral T helper subset profiling in idiopathic inflammatory myositis: Proof of concept, Reumatol.Clin (Engl Ed). 19(2023)143-149.","DOI":"10.1016\/j.reuma.2022.03.002"},{"key":"10.1016\/j.intimp.2024.112403_b0200","doi-asserted-by":"crossref","unstructured":"Q.Y. Su, H.C. Li, X.J. Jiang, et al., Exploring the therapeutic potential of regulatory T cell in rheumatoid arthritis: Insights into subsets, markers, and signaling pathways, Biomed.Pharmacother. 174(2024)116440.","DOI":"10.1016\/j.biopha.2024.116440"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924009238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924009238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T13:20:00Z","timestamp":1722345600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924009238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":40,"alternative-id":["S1567576924009238"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112403","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral Th17\/Treg imbalance in Chinese patients with untreated antisynthetase syndrome associated interstitial lung disease","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112403","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112403"}}